Schwab Charles Investment Management Inc. Sells 1,219 Shares of Aetna Inc. (AET)
Schwab Charles Investment Management Inc. cut its position in Aetna Inc. (NYSE:AET) by 0.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,184,962 shares of the company’s stock after selling 1,219 shares during the period. Schwab Charles Investment Management Inc.’s holdings in Aetna were worth $179,913,000 as of its most recent SEC filing.
A number of other institutional investors have also modified their holdings of AET. FTB Advisors Inc. increased its position in shares of Aetna by 11.0% in the first quarter. FTB Advisors Inc. now owns 977 shares of the company’s stock worth $125,000 after buying an additional 97 shares during the period. Signature Estate & Investment Advisors LLC acquired a new position in shares of Aetna during the first quarter worth approximately $133,000. Liberty Capital Management Inc. increased its position in shares of Aetna by 206.9% in the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock worth $144,000 after buying an additional 629 shares during the period. Horan Capital Management acquired a new position in shares of Aetna during the first quarter worth approximately $157,000. Finally, Guardian Life Insurance Co. of America increased its position in shares of Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock worth $173,000 after buying an additional 9 shares during the period. 91.73% of the stock is owned by institutional investors.
Shares of Aetna Inc. (NYSE:AET) opened at 152.15 on Friday. Aetna Inc. has a 1-year low of $104.59 and a 1-year high of $161.69. The stock has a market cap of $50.53 billion, a PE ratio of 33.77 and a beta of 0.54. The stock has a 50 day moving average of $154.26 and a 200 day moving average of $139.02.
Aetna (NYSE:AET) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share for the quarter, beating analysts’ consensus estimates of $2.34 by $1.08. The business had revenue of $15.52 billion during the quarter, compared to analyst estimates of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The company’s revenue was down 2.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.21 earnings per share. Equities research analysts forecast that Aetna Inc. will post $9.52 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Stockholders of record on Thursday, July 13th were given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.31%. The ex-dividend date of this dividend was Tuesday, July 11th. Aetna’s dividend payout ratio is presently 43.67%.
COPYRIGHT VIOLATION NOTICE: This piece of content was first published by Daily Political and is the property of of Daily Political. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/12/schwab-charles-investment-management-inc-sells-1219-shares-of-aetna-inc-aet.html.
Several equities analysts have issued reports on the stock. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $145.00 price target on shares of Aetna in a report on Monday, April 24th. Argus reaffirmed a “buy” rating and issued a $165.00 price target (up from $145.00) on shares of Aetna in a report on Tuesday, May 30th. Cowen and Company set a $170.00 price target on shares of Aetna and gave the stock a “buy” rating in a report on Saturday, May 27th. Credit Suisse Group reaffirmed a “buy” rating and issued a $155.00 price target on shares of Aetna in a report on Wednesday, May 17th. Finally, UBS AG reaffirmed a “buy” rating and issued a $160.00 price target (up from $147.00) on shares of Aetna in a report on Wednesday, May 17th. Eight equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. Aetna currently has an average rating of “Buy” and a consensus price target of $157.09.
In other news, Chairman Mark T. Bertolini sold 103,547 shares of the business’s stock in a transaction that occurred on Wednesday, May 17th. The shares were sold at an average price of $140.79, for a total value of $14,578,382.13. Following the completion of the transaction, the chairman now owns 659,888 shares of the company’s stock, valued at $92,905,631.52. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Margaret M. Mccarthy sold 27,028 shares of the business’s stock in a transaction that occurred on Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the completion of the transaction, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,008,606.49. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.